A new discovery in blood immune cells has put researchers one step closer to identifying a blood biomarker that would allow ...

A German research team’s discoveries about autoimmune diseases are opening up new possibilities for patients with lupus and ...

Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of ...

There is an undeniable connection between a strong immune system and nutrition. Learn why what you eat matters and other ways ...

Artificial intelligence (AI) can significantly aid in early detection of autoimmune diseases, like rheumatoid arthritis and ...

Scientists have created a new atlas of plant cells during immune response, in turn discovering a new rare cell state, called Primary IMmunE Responder (PRIMER), that acts as an immune response hub to ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company committed to developing and delivering medicines to treat patients with autoimmune and inflammatory diseases, today announced a strategic ...

Eliem Therapeutics is continuing its transformation into an immune-mediated disease company by paying $9 million to ...

Anti-inflammatory macrophages play crucial roles in various diseases, including cancer, autoimmune disorders, and wound ...

IGM Biosciences has decided to halt development of imvotamab and IGM-2644, two IgM-based bispecific antibody T cell engagers for autoimmune diseases, and cut its staff by 73%. The biotechnology ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.